Skip to main content
Caplight Logo









Meatosis

Meatosis

Private
IsraelHealthcare & Life Scienceshttps://www.meatosis.com/

Last Round

Accelerator

Apr 2, 2023

Company Overview

Meatosis is an agriculture and food technology company that develops lab-grown fish cell lines for the production of cultivated seafood products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cultivated seafoodlab-grown fishcellular agriculturealternative proteincell linescultivated meatfoodtechbiotechnologysustainable proteinIP licensingB2B biotechclean meat

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meatosis Comparables

Compare Meatosis with similar companies based on industry and business-model similarity.

Meatosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sea2Cell
88%
Forsea
87%
Umami Bioworks
85%

Meatosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 2, 2023

Meatosis Investors

Notable investors and investment history

Meatosis investors
InvestorRounds
MassChallenge IsraelAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2023

    Received funding from MassChallenge Israel and Modern Agriculture Foundation.

Meatosis Filings

Explore SEC and related filing metadata, where available.

Meatosis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Meatosis's valuation, stock price, and market status.

Is Meatosis a public or private company?

Meatosis is a private company.

What is the current stock price of Meatosis?

Meatosis is a private company with no public stock price. No recent secondary market data is available.

How much is Meatosis worth (valuation)?

Valuation information for Meatosis is not publicly available.

Can I buy Meatosis stock?

Meatosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Meatosis's last funding round?

Meatosis's most recent funding round was Accelerator on April 2, 2023.

Who are the main investors in Meatosis?

Key investors in Meatosis include MassChallenge.

Will Meatosis IPO soon?

No public IPO plans have been announced for Meatosis.

How can I track Meatosis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Meatosis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Year Founded2021
Last FundingApr 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?